Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 163(10): 5303-11, 1999 Nov 15.
Article in English | MEDLINE | ID: mdl-10553053

ABSTRACT

Immunoregulation of lymphocytes and macrophages in the peripheral immune system is achieved in part by activation-induced cell death. Members of the TNF receptor family including Fas (CD95) are involved in the regulation of activation-induced cell death. To determine whether activation-induced cell death plays a role in regulation of dendritic cells (DCs), we examined interactions between Ag-presenting murine DCs and Ag-specific Th1 CD4+ T cells. Whereas mature bone marrow- or spleen-derived DCs expressed high levels of Fas, these DCs were relatively insensitive to Fas-mediated killing by the agonist mAb, Jo-2, as well as authentic Fas ligand expressed on the CD4+ T cell line, A.E7. The insensitivity to Fas-mediated apoptosis was not affected by priming with IFN-gamma and/or TNF-alpha or by blocking the DC survival signals TNF-related activation-induced cytokine and CD40L. However, apoptosis could be induced with C2-ceramide, suggesting that signals proximal to the generation of ceramide might mediate resistance to Fas. Analysis of protein expression of several anti-apoptotic mediators revealed that expression of the intracellular inhibitor of apoptosis Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein was significantly higher in Fas-resistant DCs than in Fas-sensitive macrophages, suggesting a possible role for Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein in DC resistance to Fas-mediated apoptosis. Our results demonstrate that murine DCs differ significantly from other APC populations in susceptibility to Fas-mediated apoptosis during cognate presentation of Ag. Because DCs are most notable for initiation of an immune response, resistance to apoptosis may contribute to this function.


Subject(s)
Apoptosis/immunology , Dendritic Cells/cytology , Dendritic Cells/immunology , Signal Transduction/immunology , fas Receptor/physiology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , CD40 Antigens/metabolism , CD40 Ligand , Carrier Proteins/physiology , Cell Differentiation/immunology , Cell Line , Dendritic Cells/metabolism , Fas Ligand Protein , Granulocyte-Macrophage Colony-Stimulating Factor/physiology , Immunity, Innate , Ligands , Macrophages/cytology , Macrophages/immunology , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred MRL lpr , Mice, Mutant Strains , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B , Spleen/cytology , Spleen/immunology , Th1 Cells/metabolism , Up-Regulation/immunology , fas Receptor/biosynthesis , fas Receptor/metabolism
2.
Proc Natl Acad Sci U S A ; 92(24): 11225-9, 1995 Nov 21.
Article in English | MEDLINE | ID: mdl-7479970

ABSTRACT

The Fas/APO-1 cytotoxic pathway plays an important role in the regulation of peripheral immunity. Recent evidence indicates that this regulatory function operates through deletion of activated T and B lymphocytes by CD4+ T cells expressing the Fas ligand. Because macrophages play a key role in peripheral immunity, we asked whether Fas was involved in T-cell-macrophage interactions. Two-color flow cytometry revealed that Fas receptor (FasR) was expressed on resting murine peritoneal macrophages. FasR expression was upregulated after activation of macrophages with cytokines or lipopolysaccharide, although only tumor necrosis factor-alpha rendered macrophages sensitive to anti-FasR antibody-mediated death. To determine the consequence of antigen presentation by macrophages to CD4+ T cells, macrophages were pulsed with antigen and then incubated with either Th1 or Th2 cell lines or clones. Th1, but not Th2, T cells induced lysis of 60-80% of normal macrophages, whereas macrophages obtained from mice with mutations in the FasR were totally resistant to Th1-mediated cytotoxicity. Macrophage cytotoxicity depended upon specific antigen recognition by T cells and was major histocompatibility complex restricted. These findings indicate that, in addition to deletion of activated lymphocytes, Fas plays an important role in deletion of activated macrophages after antigen presentation to Th1 CD4+ T cells. Failure to delete macrophages that constitutively present self-antigens may contribute to the expression of autoimmunity in mice deficient in FasR (lpr) or Fas ligand (gld).


Subject(s)
Macrophages/cytology , Th1 Cells/immunology , fas Receptor/physiology , Animals , Antigen-Presenting Cells/cytology , Cell Death , Cytotoxicity, Immunologic , Immunity, Cellular , Macrophage Activation , Major Histocompatibility Complex , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred CBA , Mice, Mutant Strains , Receptors, Cell Surface/physiology , Th1 Cells/cytology , Th2 Cells/immunology
3.
Eur J Immunol ; 25(10): 2940-7, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7589095

ABSTRACT

Mice defective in Fas-mediated apoptosis (lpr phenotype) have an intrinsic B cell abnormality that predisposes them to autoantibody production. To investigate potential roles for the Fas receptor (FasR) in B cell tolerance, FasR expression and function were evaluated at different stages of B cell development. FasR expression was very low or absent on pro- and pre-B cells, but was detected in early B cell lines and was up-regulated following IFN-gamma-induced maturation of the pre-B cell line 70-Z. Whereas FasR expression was very low in resting mature sIgM+ B cells, expression was markedly increased following mitogen activation and was also elevated in two mature sIgG+ lymphoma lines. FasR expression correlated strongly with the ability of B cells to undergo Fas-mediated apoptosis. In addition, although Fas did not appear to play a direct role in apoptosis mediated by cross-linking of sIg with anti-IgM, anti-FasR and sublethal concentrations of anti-Ig were additive in the induction of apoptosis in the early B cell line WEHI 231. These findings suggest that the Fas pathway is not involved in the elimination of pro- and pre-B cells, but are compatible with an ancillary role for FasR in the elimination of early B cells and elimination of mature B cells following activation.


Subject(s)
B-Lymphocytes/cytology , Immune Tolerance , fas Receptor/physiology , Animals , Antibodies, Anti-Idiotypic/pharmacology , Apoptosis/drug effects , B-Lymphocytes/metabolism , Bone Marrow Cells , Cell Division , Cell Lineage , Immunoglobulin Fab Fragments/pharmacology , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Immunologic Capping , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/pathology , Lymphoid Tissue/cytology , Lymphoma/pathology , Mice , Mice, Inbred BALB C , Mice, SCID , Tumor Cells, Cultured , fas Receptor/biosynthesis , fas Receptor/genetics
4.
J Cell Physiol ; 164(3): 562-70, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7544356

ABSTRACT

We have investigated the phenotypic and functional characteristics of murine pre-B cells obtained in semisolid and liquid culture with stem cell factor (SCF) and interleukin 7 (IL-7). Both serum-supplemented and serum-deprived culture conditions were used. The source of bone marrow cells was either normal mice (CD1 and C3H) or the lupus strain of mice MRL/lpr and its congenic strain MRL/+. SCF (100 ng/ml) and IL-7 (250 ng/ml) supported murine B cell proliferation in vitro from all the murine strains analyzed both in serum-supplemented and serum-deprived conditions. Maximal colony growth was observed in both cases when the factors were used in combination. The growth factors alone induced some colony growth in serum-supplemented cultures but were either ineffective or had modest activity in serum-deprived cultures. Cells harvested from the colonies or generated in liquid cultures and stimulated with SCF + IL-7 in the absence of serum had almost exclusively a pre-B cell phenotype (BP-1+, B220+, slg-, CD4-, CD8-, Mac-1-, RB-6-). Both the maximal colony growth in semisolid culture and the maximal number of cells in liquid culture were observed at day 12-14. At this time, the pre-B cells failed to differentiate further and started to die. Pre-B cells generated in vitro were, however, capable of differentiating in vivo. SCID mice injected with 2 x 10(6) pre-B cells had readily detectable serum levels of IgM (54 +/- 26 micrograms/ml) and IgG (60 +/- 95 micrograms/ml) at 4 weeks and 6 weeks posttransplantation, respectively. Mature B and T cells of the donor major histocompatibility complex type were detected in the SCID mice at sacrifice 14 weeks posttransplantation. These data indicate that purified (> 80% BP-1+) populations of functional pre-B cells can be grown from murine bone marrow of normal mice as well as of lupus mice in serum-deprived cultures stimulated with SCF and IL-7. These cultures, therefore, provide a highly enriched source of pre-B cells but also contain T cell precursors that differentiate upon adoptive transfer into SCID mice.


Subject(s)
Autoimmune Diseases/immunology , B-Lymphocytes/cytology , Hematopoietic Cell Growth Factors/pharmacology , Interleukin-7/pharmacology , T-Lymphocytes/cytology , Animals , B-Lymphocytes/immunology , Bone Marrow Cells , Cell Differentiation/drug effects , Cells, Cultured , Culture Media , Hematopoiesis/drug effects , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/cytology , Immunophenotyping , In Vitro Techniques , Mice , Mice, Inbred C3H , Mice, Mutant Strains , Mice, SCID , Spleen/cytology , Stem Cell Factor , T-Lymphocytes/immunology
5.
Int Rev Immunol ; 11(4): 283-93, 1994.
Article in English | MEDLINE | ID: mdl-7806942

ABSTRACT

The ability of SCID mice to accept xenografts has been exploited to study the survival, function and potential of peripheral blood mononuclear cells (PBMC) from patients with autoimmune disorders to produce tissue injury in the mouse. Studies performed with PBMC obtained from patients with organ specific and multisystem autoimmune diseases indicate that human PBMC survive in SCID mice for several months, produce IgG and autoantibodies with the same specificities as are found in the donor. Tissue injury is not generally observed in the SCID mouse recipient. SCID mice have also been partially reconstituted with bone marrow from BB (diabetic) and MRL (lupus) mice. SCID mice injected with both spleen cells from mice with collagen induced arthritis together with native bovine collagen developed more severe arthritis than the donors. SCID mice have therefore proven to be a useful resource to study autoimmunity. In both xeno- and allografts of mature lymphocytes, graft versus host reactions occur. Further studies will be necessary to improve donor cell survival without aggravating graft versus host disease.


Subject(s)
Autoimmunity , Mice, SCID/immunology , Animals , Autoimmune Diseases/immunology , Graft Survival/immunology , Graft vs Host Disease/immunology , Humans , Immunotherapy, Adoptive , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/transplantation , Mice , Rats , Transplantation, Heterologous , Transplantation, Homologous
6.
Br J Rheumatol ; 32(1): 4-12, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8422557

ABSTRACT

Peripheral blood mononuclear cells (PBMC) injected into severe combined immune deficiency (SCID) mice continue to secrete human immunoglobulin and respond to immunization with recall antigens. PBMC for patients with autoimmune diseases produce autoantibodies of the same specificities but at lower levels compared to the donor. SCID recipients of patients' PBMC fail to develop clinical disease although some histological lesions suggestive of autoimmunity have been reported. Transfer of autoimmunity from rodents to SCID mice has been successful in some instances. Despite obstacles related to limited survival and varying degrees of graft vs host disease (GVHD), SCID mice should prove to be a useful vehicle to explore autoantibody regulation.


Subject(s)
Autoimmune Diseases , Mice, SCID/immunology , Animals , Disease Models, Animal , Mice
7.
Clin Exp Immunol ; 90(3): 466-75, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1458684

ABSTRACT

MRL/lpr (lpr) mice spontaneously develop a lupus-like illness as well as massive lymphadenopathy. Attempts to transfer autoimmunity by adoptive transfer or radiation bone marrow chimeras have been unsuccessful. Since severe combined immunodeficiency (SCID) mice have been engrafted with human and rat xenografts without apparent graft-versus-host disease (GVHD), we subjected SCID mice to low-dose irradiation and reconstituted the mice with spleen cells from young or old lpr mice or with lpr bone marrow. Fourteen out of twenty (70%) of SCID mice engrafted with spleen cells from old lpr mice produced autoantibodies (anti-DNA and anti-Sm) without evidence of the severe lymphoid atrophy previously described for lpr spleen-->+/+ chimeras. SCID mice engrafted with spleen cells from young lpr mice developed acute GVHD and 5/6 (83%) died within 4 weeks post-transfer. Although 8/11 (73%) of lpr-->SCID bone marrow allografts survived for at least 4 months, these mice developed a wasting disease characterized by lymphoid atrophy and fibrosis without the production of autoantibodies. None of the lpr-->SCID grafts resulted in the transfer of double negative T cells or the lymphoproliferative syndrome characteristic of MRL/lpr mice. These findings indicate that SCID mice can be engrafted with splenocytes from old MRL/lpr mice and that B cells continue to secrete autoantibodies for several months in the SCID recipients. This study also demonstrates that, unlike i.p. transplant of xenogeneic cells, acute GVHD is a consistent feature of i.p. transplants of normal allogeneic mononuclear cells into SCID mice.


Subject(s)
Autoantibodies/biosynthesis , Graft vs Host Disease/immunology , Mice, SCID/immunology , Transplantation, Homologous/immunology , Animals , Autoantibodies/analysis , Chimera , Flow Cytometry , Graft Survival , Immunoglobulin Allotypes/analysis , Immunoglobulin G/blood , Liver/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, SCID/genetics , Spleen/pathology , Spleen/transplantation
8.
Clin Exp Immunol ; 88(1): 84-90, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1563110

ABSTRACT

Mice with SCID disease have previously been successfully engrafted with human peripheral blood mononuclear cells (PBMC) obtained from normal individuals and from patients with various diseases. To determine whether SCID mice engrafted with SLE PBMC produced autoantibodies with specificities similar to those in the SLE donor, and to investigate which variables influence autoantibody production in the SCID recipients, we injected PBMC from 16 SLE patients into SCID mice and tested the recipients for autoantibodies to DNA and to five recombinant autoantigens. Ten out of 16 (68%) lupus and six out of nine (67%) normal grafts were successful as determined by the presence of human IgG greater than or equal to 5 micrograms/ml of SCID serum post-transfer. Autoantibodies to La/SSB, Ro/SSA, and RNP were detected in five out of 10 SCID-SLE recipients by ELISA and immunoblotting up to 22 weeks post-engraftment. The detection of autoantibodies in SCID-SLE mice was more closely related to autoantibody levels in donor sera than to total IgG concentrations in the SCID recipients. Autoantibody activity/mg IgG was similar in the donor and recipient sera. Histological evaluation of eight SCID-SLE mice killed 4-22 weeks post-transfer revealed population of the SCID thymus and spleen with mononuclear cells, but no evidence of lupus nephritis or dermatitis. These findings indicate that SCID mice can be engrafted with PBMC from patients with lupus and that specific autoantibodies are produced up to 5 months post-transfer. Failure to develop glomerulonephritis may be explained by low or absent anti-DNA antibodies or by changes in the cellular composition of the PBMC grafts.


Subject(s)
Autoantibodies/biosynthesis , Chimera/immunology , Lupus Erythematosus, Systemic/immunology , Mice, SCID/immunology , Animals , Enzyme-Linked Immunosorbent Assay , Graft vs Host Disease/immunology , Humans , Immunoglobulin G/analysis , Mice , Thymus Gland/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...